Iperion

Iperion AAQS

The The AAQS of Iperion (IPR.NZ) as of Nov 17, 2026 is 2. In the previous year, The AAQS was 2.00 — a change of 0.00% (lower).

AAQS

2

YoY

0.00%

Last updated:

Iperion has a current AAQS of 2.

A high AAQS can be seen as a positive indicator that the company is developing successfully.

Investors can assume that the company is on a good path to generate profits.

On the other hand, it is important to consider the AAQS of the stock Iperion in comparison to the profits generated and other companies in the same industry. A high AAQS is not an absolute guarantee for a positive future. Only in this way can one get a complete picture of the company's performance.

In order to better assess the company's development, it is important to consider the AAQS in comparison to other companies in the same industry. In general, investors should always consider the AAQS of a company in connection with other fundamentals such as profit, EBIT, cash flow, and others in order to make an informed investment decision.

The Iperion AAQS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

AAQS
Date
AAQS
Jan 1, 2018
2.00 NZD
Jan 1, 2019
2.00 NZD
Jan 1, 2020
2.00 NZD
Jan 1, 2021
2.00 NZD
Jan 1, 2022
2.00 NZD
Jan 1, 2023
2.00 NZD
Jan 1, 2024
2.00 NZD
Jan 1, 2025
2.00 NZD
The Iperion AAQS history
YEARAAQSYoY
20.00%
20.00%
20.00%
20.00%
20.00%
20.00%
20.00%
20.00%
20.00%
20.00%
20.00%
2—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Iperion Stock analysis

What does Iperion do? Iperion Ltd, listed on the New Zealand stock exchange with ticker IPR.NZ and ISIN NZLATE0001S2, is headquartered in Auckland, New Zealand. The company operates within the Information Technology sector, specifically in the Technology industry. Iperion Ltd went public through an IPO on August 18, 2014. Its official website is http://www.lateralcorp.com/, though this appears to be a different entity, as the domain name does not align with the company's name. The company's activities are not detailed in the provided information, and no specific products, services, or financial figures are mentioned. The source description provided, which refers to Southern Charter Financial Group Ltd as a shell company focused on antimicrobial compounds, is not relevant to Iperion Ltd and should not be considered part of the company's profile. Iperion Ltd's profile is limited to its stock exchange listing, headquarters location, sector, industry, IPO date, and website, with no additional details available from the given data. Iperion is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Iperion stock

The AAQS of Iperion is 2 in 2025.

On Eulerpool you can find the complete historical development of The AAQS Iperion since 2006 – with annual values, charts, and detailed analysis.

The AAQS is a key figure developed by AlleAktien.

The AAQS is a key figure developed by AlleAktien.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — Iperion

All Key Metrics — Iperion